Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
459.44
-6.30 (-1.35%)
Dec 3, 2024, 1:53 PM EST - Market open

Vertex Pharmaceuticals Market Cap

Vertex Pharmaceuticals has a market cap or net worth of $118.25 billion as of December 3, 2024. Its market cap has increased by 33.79% in one year.

Market Cap
118.25B
Enterprise Value
110.49B
1-Year Change
33.79%
Ranking
Category
Stock Price
$459.17

Market Cap Chart

Since December 1, 1998, Vertex Pharmaceuticals's market cap has increased from $611.50M to $118.25B, an increase of 19,237.65%. That is a compound annual growth rate of 22.42%.

History

DateMarket Cap% Change
Dec 2, 2024119.94B14.39%
Dec 29, 2023104.85B41.44%
Dec 30, 202274.13B32.76%
Dec 31, 202155.83B-9.15%
Dec 31, 202061.46B9.15%
Dec 31, 201956.30B32.95%
Dec 31, 201842.35B11.74%
Dec 29, 201737.90B107.41%
Dec 30, 201618.27B-40.90%
Dec 31, 201530.92B8.21%
Dec 31, 201428.57B64.52%
Dec 31, 201317.37B91.17%
Dec 31, 20129.09B31.16%
Dec 30, 20116.93B-2.69%
Dec 31, 20107.12B-8.32%
Dec 31, 20097.76B69.85%
Dec 31, 20084.57B48.74%
Dec 31, 20073.07B-34.61%
Dec 29, 20064.70B71.34%
Dec 30, 20052.74B223.10%
Dec 31, 2004848.90M5.56%
Dec 31, 2003804.20M-33.56%
Dec 31, 20021.21B-34.33%
Dec 31, 20011.84B-56.32%
Dec 29, 20004.22B370.22%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Amgen 152.05B
Stryker 149.49B
Pfizer 148.53B
Boston Scientific 133.62B
Sanofi 121.80B
Bristol-Myers Squibb Company 120.11B
Gilead Sciences 115.38B
Medtronic 110.97B
Market Cap Rankings